Digest Network Come funziona
Network
/
Società
Se
Non verificato

Secretome Therapeutics

Di cosa scriviamo

BiotecnologiaCardiologiaIndustriaSaluteScienza

5 comunicati stampa

Guarda tutti i comunicati
28/10/2025
Industria
Scienza
Medicina - Varie
Biologia
Cardiologia
Associazioni/Professionisti
Biotecnologia
Salute
Secretome Therapeutics Initiates Phase 1 Clinical Trial of STM-01 in Patients with Dilated Cardiomyopathy
Fonte
Secretome Therapeutics
Emittente
Business Wire
1.00
0
22/04/2025
Mercato del lavoro
Salute
Scienza
Farmaceutica
Cardiologia
Biotecnologia
Secretome Therapeutics Appoints Dr. Marshelle Smith Warren as Chief Medical Officer
Fonte
Secretome Therapeutics
Emittente
Business Wire
1.00
0
25/03/2025
Industria
Scienza
Medicina - Varie
Biologia
Cardiologia
Biotecnologia
Salute
Farmaceutica
Secretome Therapeutics Announces First Patient Dosed in Groundbreaking Phase 1 Study of STM-01 in Heart Failure with Preserved Ejection Fraction
Fonte
Secretome Therapeutics
Emittente
Business Wire
1.00
0
20/03/2025
Industria
Sanità
Scienza
Farmaceutica
Medicina - Varie
Cardiologia
Biotecnologia
Igiene alimentare
Salute
Secretome Therapeutics Granted FDA Fast Track Designation for STM-01, a Neonatal Cardiac Progenitor Cell Therapy for HFpEF
Fonte
Secretome Therapeutics
Emittente
Business Wire
1.00
0
25/11/2024
Cardiologia
Biologia
Biotecnologia
Salute
Sanità
Farmaceutica
Scienza
Medicina - Varie
Industria
Secretome Therapeutics Closes $20.4 Million Financing Round to Advance Cardiomyopathy and Heart Failure Therapies
Fonte
Secretome Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0